Results summary | View all lists in L2L MDB | View all genes in C02A.profile.d50 |
Down-regulated at least 1.4-fold following treatment of MCF-7 human breast carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 8.99-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
215073_S_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
216048_S_AT | RHOBTB3 | ![]() |
![]() |
Rho-related BTB domain containing 3 | |||||||||
209128_S_AT | SART3 | R | ![]() |
![]() |
squamous cell carcinoma antigen recognized by T cells 3 |